BiotechTube

Epidiolex

Pre-clinicalRecruiting
0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Maternal Complications

Conditions

Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse, Pregnancy

Trial Timeline

Aug 5, 2025 → Aug 31, 2033

NCT ID
NCT06113237

About Epidiolex

Epidiolex is a pre-clinical stage product being developed by Jazz Pharmaceuticals for Maternal Complications. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06113237. Target conditions include Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse.

Hype Score Breakdown

Clinical
3
Activity
15
Company
12
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT06113237Pre-clinicalRecruiting
NCT05772429Pre-clinicalActive

Competing Products

2 competing products in Maternal Complications

See all competitors
ProductCompanyStageHype Score
SPIKEVAXModernaPreclinical
0
PegvaliaseBioMarin PharmaceuticalPre-clinical
30